Overview
The GMO Emerging Country Debt Fund’s objective is total return in excess of the J.P. Morgan Emerging Markets Bond Index Global Diversified (EMBIG-D). Since its inception in 1994, the Fund has employed a broad opportunity set, investing across all forms of emerging market debt, including securities, derivatives, and private instruments, in both hard and local currencies. The investable universe covers a wide range of issuer types (sovereigns, corporates, project finance) and credit qualities defined by credit rating agencies, ranging from high credit quality (e.g., AA) to default (e.g., D), though the portfolio’s overall duration, currency, country, and credit quality exposures are managed mindful of the EMBIG-D.
In achieving its objective, the strategy emphasizes “arbitrage-like” opportunities over country, currency, or duration positions. We take an arbitrage-pricing approach to identifying mispriced instruments across a wide array of instruments in any given country: hard and local currency debt issues, quasi-sovereign corporate debt issues, credit default swaps, linkers, interest rate swaps, and supranationals, among others. Given the wide range of credit qualities in the reference benchmark (AA to default), the team has developed expertise in managing performing, distressed, and defaulted issuers, including workout processes as needed. This enables the Fund to opportunistically capture country-specific alpha from markets undergoing default or restructuring. In corporate debt, the focus is on quasi-sovereign entities, which offer a more attractive risk/reward profile than private corporates.
The Fund leverages deep expertise in global emerging and frontier local markets to selectively invest in currencies and local interest rates when valuations are compelling. However, due to its hard-currency benchmark, these positions are typically not a major source of excess return.
Facts
Performance
Documents
Literature
| ESG Report | Download | |
| Download All | Download |
Downloads
Commentary & Attribution
| Commentary Quarterly | Download | |
| Attribution - Monthly | Download | |
| Attribution - YTD | Download | |
| Download All | Download |
Risks
Risks associated with investing in the Fund may include: (1) Credit Risk: the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner; (2) Market Risk - Fixed Income Investments: the market price of a fixed income investment can decline due to a number of market-related factors, including rising interest rates and widening credit spreads or decreased liquidity stemming from the market's uncertainty about the value of a fixed income investment (or class of fixed income investments); and (3) Illiquidity Risk: Low trading volume, lack of a market maker, large position size, or legal restrictions may limit or prevent the Fund from selling particular securities or closing derivative positions at desirable prices. For a more complete discussion of these and other risks, please consult the Fund's Prospectus.
Disclosures
An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above.
The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.